Content about Ciba Specialty Chemicals

February 17, 2011
Novartis names Naomi Kelman as new head of the Novartis OTC division

Novartis on Thursday morning named Naomi Kelman head of the Novartis OTC division, effective March 2. She will report directly to Joseph Jimenez, Novartis CEO.

BASEL, Switzerland — Novartis on Thursday morning named Naomi Kelman head of the Novartis OTC division, effective March 2. She will report directly to Joseph Jimenez, Novartis CEO.

The Novartis OTC and animal health businesses will become separate Novartis divisions, in addition to the pharmaceuticals, Sandoz (generics), vaccines and diagnostics divisions. As previously announced, following the completion of the merger between Novartis and Alcon, CIBA Vision and Novartis ophthalmic medicines will be merged into the new Alcon eye care division of Novartis.

December 15, 2010
Novartis positions itself as eye care giant with Alcon merger

Novartis on Wednesday announced that its merger agreement with Alcon has been settled to the tune of $12.9 billion. The new $8.7 billion Alcon eye care division, which includes CIBA Vision and selected ophthalmic medicines, will be led by current Alcon president and CEO Kevin Buehler.

BASEL, Switzerland — Novartis on Wednesday announced that its merger agreement with Alcon has been settled to the tune of $12.9 billion. The new $8.7 billion Alcon eye care division, which includes CIBA Vision and selected ophthalmic medicines, will be led by current Alcon president and CEO Kevin Buehler.

Shares of Novartis were up 7.6% to more than $60 in early morning trading.

"The full merger is the logical conclusion of our initial strategic investment in Alcon,” stated Daniel Vasella, Novartis chairman.

January 3, 2010
Novartis announces merger proposal for Alcon

With an eye to the future, Novartis brass envisions a growth arena driven by the...

NEW YORK With an eye to the future, Novartis brass envisions a growth arena driven by the aging Boomer population — eye care, along with all of the products, medicines and surgeries associated with eye care.